Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
<h4>Background</h4>The systemic immune-inflammation index (SII), which is calculated using absolute platelet, neutrophil, and lymphocyte counts, has recently attracted attentions as a prognostic indicator in patients with solid malignancies. In the current study, we retrospectively inves...
Main Authors: | Sho Matsubara, Seiji Mabuchi, Yoshinori Takeda, Naoki Kawahara, Hiroshi Kobayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0248871 |
Similar Items
-
Prognostic significance of tumor laterality in advanced ovarian cancer
by: Yuki Yamada, et al.
Published: (2021-11-01) -
Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer
by: Yihong Huang, et al.
Published: (2021-10-01) -
Prognostic value of systemic immune-inflammation index in the diagnosis of preeclampsia
by: Mucahit Kapci, et al.
Published: (2024-03-01) -
Prognostic value of hematological indexes in endometrioid type endometrial cancer
by: Serife Ozlem Genc, et al.
Published: (2024-04-01) -
The Predictive and Prognostic Value of the Systemic Immune-Inflammation Index for Congestive Heart Failure
by: Zhihao Zheng, et al.
Published: (2024-11-01)